Profound Medical Corp.
PROF
$4.71
$0.183.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.05% | 43.04% | -35.34% | -5.07% | 23.99% |
| Total Depreciation and Amortization | -23.11% | -4.93% | -7.85% | -3.20% | 204.88% |
| Total Amortization of Deferred Charges | -- | -402.22% | 0.00% | -- | -- |
| Total Other Non-Cash Items | 326.15% | -177.53% | -23.64% | 27.47% | -29.51% |
| Change in Net Operating Assets | 448.35% | -90.91% | 397.18% | -163.83% | 461.70% |
| Cash from Operations | -46.81% | 11.33% | -0.20% | -40.21% | 38.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 44.55% | 21.35% | 1.63% | -8.51% | -206.90% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | 573,350.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -100.81% | 5,461.35% | 1.48% | -103.30% | 10,379.40% |
| Foreign Exchange rate Adjustments | 104.23% | -3,186.11% | 194.74% | 92.08% | -927.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.51% | 499.50% | 2.04% | -147.44% | 301.93% |